Humanised Igg1 Monoclonal Antibody Against Human Latent Myostatin

2 trials

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

4 Countries

Phase II

Phase II: 2

Indications tested

Facioscapulohumeral muscular dystrophy 1 Overweight 1 Obesity 1

Sponsors using this IMP

F. Hoffmann-La Roche AG 2

All trials

2 total

A Trial to Study the Safety and Efficacy of a New Drug Combination for Weight Loss While Maintaining Muscles Ended

2024-519561-22-00 Phase II 2 countries F. Hoffmann-La Roche AG
A Study to Evaluate the Pharmacodynamics, Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7204239 in Participants with Facioscapul… Ended

2022-503117-36-00 Phase II 2 countries F. Hoffmann-La Roche AG

Showing 1–2 of 2 trials

← All drugs A–Z